ASRM 2019 — Preconception male cannabis use linked to spontaneous abortion


  • Daniel M. Keller, Ph.D
  • Conference Reports
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Male cannabis use once or more times per week in the 2 months prior to conception was associated with an approximate doubling of the risk of spontaneous abortion (SAB) in his partner.

Why this matters

  • As cannabis use is common and increasing with decriminalization, clinicians should be aware of this factor in pregnancy loss.

Study design  

  • Prospective study using Pregnancy Study Online preconception cohort.
  • Females 21-45 years; males ≥21 years; attempting to conceive; not using fertility treatment.
  • Male cannabis use in 2 months prior to baseline: none;
  • Follow-up with female partner for 12 months or until pregnancy reported.
  • SAB defined as pregnancy loss at
  • Study funded by National Institutes of Health.

Key results

  • n=1535 couples.
  • Total SABs: 17.5%.
  • Only users ≥1 time/week had elevated SAB: adjusted HR (aHR) vs nonusers: aHR, 2.04 (95% CI, 1.28-3.24).
  • Only users ≥1 time/week had elevated aHR for ≥3 cycles pregnancy attempts at baseline vs nonusers (aHR, 3.8; 95% CI, 1.7-5.0).
  • SAB risk was higher at

Limitations

  • No data on time-varying cannabis use.
  • Cannabis exposure misclassification likely.
  • Possible selection bias.
  • Residual confounding.